Gilead Sciences Inc.

NAS : GILD
Pharmaceuticals
Foster City CA
2013 Revenue (US$ Millions)$11,202
2012 Revenue (US$ Millions)$9,703
Revenue Growth (%)15.45%
Net Income (US$ Millions)$3,075
Common Shares Outstanding (Millions)$1,534
Earnings Per Share (US$)$1.81
Price To Earnings Ratio79.36
Total Equity (US$ Millions)$11,369
Profit Margin (%)27.45%
Return On Equity (%)33.03%
Long Term Debt (US$ Millions)$4,095
Debt To Equity Ratio (%)0.36%
Market Capitalization (US$ Millions)$115,234
Total Assets (US$ Millions)$22,497
Return on Assets (%)14.48
Current Assets (US$ Millions)$7,274
Inventories (US$ Millions)$2,056
Current Liabilities (US$ Millions)$6,325
Cost of Goods Sold (US$ Millions)$2,859
Asset Turnover0.5
Inventory Turnover1.5
ExchangeNAS